JP2024511881A5 - - Google Patents
Info
- Publication number
- JP2024511881A5 JP2024511881A5 JP2023560997A JP2023560997A JP2024511881A5 JP 2024511881 A5 JP2024511881 A5 JP 2024511881A5 JP 2023560997 A JP2023560997 A JP 2023560997A JP 2023560997 A JP2023560997 A JP 2023560997A JP 2024511881 A5 JP2024511881 A5 JP 2024511881A5
- Authority
- JP
- Japan
- Prior art keywords
- dimethyl
- cyclopropyl
- azabicyclo
- carboxamide
- hexane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2104742.8A GB202104742D0 (en) | 2021-04-01 | 2021-04-01 | Sars-Cov-2 MPRO inhibitor compounds |
| GB2104742.8 | 2021-04-01 | ||
| GB2107026.3 | 2021-05-17 | ||
| GBGB2107026.3A GB202107026D0 (en) | 2021-05-17 | 2021-05-17 | SARS-COV-2 MPRO inhibitor compounds |
| PCT/GB2022/050836 WO2022208113A1 (en) | 2021-04-01 | 2022-04-01 | Sars-cov-2 mpro inhibitor compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511881A JP2024511881A (ja) | 2024-03-15 |
| JP2024511881A5 true JP2024511881A5 (https=) | 2025-04-09 |
Family
ID=81307814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560997A Pending JP2024511881A (ja) | 2021-04-01 | 2022-04-01 | ＳＡＲＳ－ＣＯＶ－２ Ｍｐｒｏ阻害剤化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240217930A1 (https=) |
| EP (1) | EP4313305A1 (https=) |
| JP (1) | JP2024511881A (https=) |
| KR (1) | KR20240004275A (https=) |
| AU (1) | AU2022247287A1 (https=) |
| CA (1) | CA3213008A1 (https=) |
| WO (1) | WO2022208113A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022306289A1 (en) | 2021-07-09 | 2024-01-18 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| WO2023043816A1 (en) | 2021-09-17 | 2023-03-23 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
| GB202214644D0 (en) * | 2022-10-05 | 2022-11-16 | Heptares Therapeutics Ltd | Sars-cov-2 mpro inhibitors and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1385870T3 (da) * | 2000-07-21 | 2010-07-05 | Schering Corp | Peptider som inhibitorer af NS3-serinprotease fra hepatitis C-virus |
| US7244721B2 (en) * | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| EP4146267A1 (en) * | 2020-05-08 | 2023-03-15 | The Board of Trustees of the Leland Stanford Junior University | Protease inhibitors for treatment or prevention of coronavirus disease |
-
2022
- 2022-04-01 CA CA3213008A patent/CA3213008A1/en active Pending
- 2022-04-01 KR KR1020237033735A patent/KR20240004275A/ko active Pending
- 2022-04-01 EP EP22716453.0A patent/EP4313305A1/en active Pending
- 2022-04-01 WO PCT/GB2022/050836 patent/WO2022208113A1/en not_active Ceased
- 2022-04-01 AU AU2022247287A patent/AU2022247287A1/en not_active Abandoned
- 2022-04-01 US US18/553,596 patent/US20240217930A1/en active Pending
- 2022-04-01 JP JP2023560997A patent/JP2024511881A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024511881A5 (https=) | ||
| RU2494095C2 (ru) | Модифицированные миметики лизина | |
| CN105283177B (zh) | 用作组蛋白脱甲基酶kdm1a的抑制剂的环丙胺衍生物 | |
| JP2023529354A5 (https=) | ||
| RU2471781C2 (ru) | Новые двузамещенные фенилпирролидины в качестве модуляторов кортикальной катехоламинергической нейротрансмиссии | |
| TWI272267B (en) | Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors | |
| JP2023509375A5 (https=) | ||
| CN104395288B (zh) | 用于治疗尤文肉瘤家族肿瘤的方法和组合物 | |
| RU2018127315A (ru) | Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунологических и аутоиммунных заболеваний | |
| SI9420017A (en) | Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids | |
| RU2012138257A (ru) | Замещенные пирролидин-2-карбоксамиды | |
| TW394769B (en) | Acylaminoindole derivatives, intermediates for their preparation, and pharmaceutical compositions containing them | |
| TWI664166B (zh) | Ｋｃｎｑ２至５通道活化劑 | |
| CN105121430A (zh) | 用于治疗自身免疫性和炎性疾病的类维生素A相关的孤儿受体γ(RORγ)的调节剂 | |
| JP2020514316A5 (https=) | ||
| JP2021513972A (ja) | 社会的機能障害の治療方法 | |
| JP2012509940A5 (https=) | ||
| AR072262A1 (es) | COMBINACION -408, QUE COMPRENDE N-CICLOHEXIL-N3-[2-(3-FLUOROFENIL)ETIL]-N-(2-{[2-(4-HIDROXI-2-OXO-2,3-DIHIDRO-1,3-BENZOTIAZOL-7-IL)ETIL]AMINO}ETIL- beta-ALANINAMIDA.USO. METODO. CONJUNTO DE ELEMENTOS. COMPOSICION FARMACEUTICA. INTERMEDIARIO. | |
| JP2024545135A5 (https=) | ||
| JP2023545046A5 (https=) | ||
| JPWO2009136625A1 (ja) | 環状アミン−１−カルボン酸エステル誘導体およびそれを含有する医薬組成物 | |
| JP2019516707A5 (https=) | ||
| JP2016512232A5 (https=) | ||
| JP2023525359A5 (https=) | ||
| JP2018522916A5 (https=) |